Red Circle
 |
||
|---|---|---|
Participation
| Dr. Naghavi | ||||
|---|---|---|---|---|
| Dr. Naghavi is an innovative medical doctor and researcher with interests in preventive cardiology, medical technology, and home healthcare. He graduated as a M.D. from Tehran University and was trained as a cardiovascular physician scientist under distinguished cardiologists Dr. S. Ward Casscells III and Dr. James T. Willerson at the Texas Heart Institute and the University of Texas Health Science Center in Houston. Dr. Naghavi is internationally recognized as a leader in heart attack prevention initiatives. Through his years of efforts in advancing the field of preventive cardiology, Dr. Naghavi founded the Society for Heart Attack Prevention and Eradication (SHAPE) and is the Executive Chairman of the SHAPE Task Force, an international non-profit coalition to overhaul the traditional (ineffective) methods of identifying individuals at risk of a near future heart attack. In 2009, the SHAPE organization helped pass Texas legislation HB1290 as the first heart attack preventive screening law in the United States. Dr. Naghavi has a number of collaborative academic research projects including NIH and NSF funded studies. He has numerous publications in scientific journals, most notably two major consensus statements (Part I and Part II) and the SHAPE Guidelines. He is also the editor of “Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment”, the most comprehensive textbook on risk assessment of the Vulnerable Patient. Along with academic activities, Dr. Naghavi is also an inventor and entrepreneur with over 30 patents and 5 companies one of which is listed on NASDAQ: VOLC. He is currently the President and CEO of Fairway Medical Technologies and IN3 Ventures. Dr. Naghavi is passionate about transforming new ideas into healthcare solutions, and welcomes innovative proposals from physicians, engineers, and entrepreneurs. | ||||
Participation
| Dr. Hecht | ||||
|---|---|---|---|---|
|
Harvey Hecht, M.D. Is an expert in cardiac imaging and preventive
cardiology, and is the author of more than 100 publications in peer
reviewed journals. He completed his internship and residency in Internal
Medicine at the Albert Einstein College of Medicine and Mount Sinai
Hospital (NY) and a fellowship in Cardiology at Beth Israel Hospital,
Harvard Medical School. His academic appointments have included
Instructor in Medicine at Harvard Medical School, Assistant Professor at
UCLA, Associate Professor at the University of Southern California and
University of California, San Francisco, and Clinical Professor of
Medicine at the Albert Einstein College of Medicine . A graduate of
Columbia College and the Albert Einstein College of Medicine, Dr. Hecht
is board certified in Internal Medicine and Cardiovascular Diseases, and
is a Fellow of the American College of Cardiology. He is a consultant to
the editors of numerous cardiovascular publications, including the
Journal of the American College of Cardiology, American Journal of
Cardiology, Circulation, American Heart Journal, Journal of Invasive
Cardiology, and the Journal of the American Society of Echocardiography.
He is one of the founders of, and was the first President of the Society
of Atherosclerosis Imaging, as well as one of the founders of the
Society of Cardiovascular Computed Tomography. He has been involved in
early stage development of several startup companies in the medical
arena which have had successful IPO’s. Dr. Hecht is the Chairman of the
Endothelix Scientific Advisory Board. Email: hhecht@myredcircle.com |
||||
Participation
 |
Dr. Yen | |||
|---|---|---|---|---|
|
Albert Yen, M.D. is a physician scientist with over 10 years of experience in basic and clinical research trial design, medical device commercialization, and small business administration. He received his medical degree from Baylor College of Medicine, where he also completed his Neurology residency and Clinical Neurophysiology fellowship training. Dr. Yen has a special interest in developing strategies for preventing heart attacks and strokes and strongly believes that a personalized weight management program can play an important role in preventive cardiology and neurology. His other interests include cerebrovascular disease, neurodegenerative conditions, traumatic brain injury, primary headache disorders, and urological neuromodulation.
Dr. Yen currently serves as VP of Medical Affairs for Fairway Medical Technologies, the business development group behind the Red Circle program.
Email: ayen@myredcircle.com
|
||||
 |
|---|
Central Location: 6320 Richmond Ave, Houston, TX 77057 | 713-781-7332 Email
 |
See us on YouTube |  |
Join us on Facebook |  |
Follow us on Twitter |
|---|